1. Home
  2. CPHI vs SYNX Comparison

CPHI vs SYNX Comparison

Compare CPHI & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.31

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

HOLD

Current Price

$0.96

Market Cap

6.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPHI
SYNX
Founded
N/A
2005
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
6.5M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
CPHI
SYNX
Price
$1.31
$0.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
52.8K
240.6K
Earning Date
11-12-2025
09-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,052,266.00
$6,003,000.00
Revenue This Year
N/A
$32.35
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$0.73
52 Week High
$3.35
$6.49

Technical Indicators

Market Signals
Indicator
CPHI
SYNX
Relative Strength Index (RSI) 33.94 45.57
Support Level $1.30 $0.73
Resistance Level $1.49 $0.86
Average True Range (ATR) 0.13 0.12
MACD -0.03 0.03
Stochastic Oscillator 1.72 67.42

Price Performance

Historical Comparison
CPHI
SYNX

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: